4640 SW Macadam Ave, Ste. 200A
Portland, OR 97239
Aronora, Inc. is a translational biotechnology company that develops safe antithrombotic (?blood-thinning?) biologics for cardiovascular emergencies. In principle, Aronora builds value into and invests in the development of unique product candidates that are in early preclinical stages, and only if the product candidates have already demonstrated superior safety and efficacy in primate disease models.